Kura Oncology, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €677.94M +53.6% €106.81M -266.5% 15.8% +0.30 pp N/A N/A
    (estimated) €441.25M +82.8% -€64.16M -57.9% -14.5% +0.49 pp N/A N/A
    (estimated) €241.35M +39.4% -€152.35M -8.3% -63.1% +0.33 pp N/A N/A
    (estimated) €173.17M +37.5% -€166.06M +13.1% -95.9% +0.21 pp N/A N/A
    (estimated) €125.97M +174.1% -€146.84M -1.0% -116.6% +2.1 pp N/A N/A
    €45.96M +∞% -€148.40M +14.0% -322.9% -3.2 pp €114.97M -208.1% 250.2% +2.5 pp
    €0.00 +NaN% -€130.19M +12.2% N/A -€106.33M +13.9% N/A
    €0.00 +NaN% -€116.06M +4.7% N/A -€93.34M +5.8% N/A
    €0.00 +NaN% -€110.81M +45.3% N/A -€88.20M +52.8% N/A
    €0.00 +NaN% -€76.28M +41.6% N/A -€57.71M +23.6% N/A
    €0.00 +NaN% -€53.86M +4.5% N/A -€46.71M +12.5% N/A
    €0.00 +NaN% -€51.56M +70.6% N/A -€41.50M +71.1% N/A
    €0.00 +NaN% -€30.22M +28.6% N/A -€24.26M +12.2% N/A
    €0.00 +NaN% -€23.51M +21.8% N/A -€21.62M +41.9% N/A
    €0.00 +NaN% -€19.30M +105.4% N/A -€15.23M +725,072.6% N/A
    €0.00 +NaN% -€9.39M +40,218.5% N/A -€2.10K -89.9% N/A
    €0.00 +NaN% -€23.30K +1.0% N/A -€20.83K +7.7% N/A
    €0.00 +NaN% -€23.06K +20.7% N/A -€19.34K +17.8% N/A
    €0.00 +NaN% -€19.10K +0.0% N/A -€16.41K +0.0% N/A
    €0.00 +NaN% -€19.10K +12.0% N/A -€16.41K -9.9% N/A
    €0.00 +NaN% -€17.06K -40.5% N/A -€18.22K -32.7% N/A
    €0.00 -€28.68K N/A -€27.09K N/A

    Notifications